Search - tctmd.com

Displaying 1 - 20 of 28

Sort: Relevancy | Date

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2018

Shelley Wood

November 30, 2018

News Daily News

Female Cardiologists and Interventionalists Rare, Isolated in Australia and New Zealand

Shelley Wood

November 22, 2018

News Daily News

ODYSSEY Outcomes Published as New Cholesterol Guidelines Loom

Michael O'Riordan

November 07, 2018

News Daily News

SORT-OUT IX: Statistical Mix-up Turns Trial’s Primary Endpoint Around

Michael O'Riordan

November 06, 2018

News Conference News AHA 2018

AHA 2018: New Cholesterol Guidelines, Fish Oil, Diabetes Meds, and Inflammation Blow Into the Windy City

Shelley Wood

November 05, 2018

News Features

The Price of Knowledge: Industry-Sponsored Studies in the Era of Evidence-Based Medicine

Shelley Wood

October 22, 2018

News Conference News TCT 2018

Twitter, Bias, and Trial Tweaks: ISCHEMIA Invites Debate on Study Designs and Endpoint Combos

Michael O'Riordan

October 02, 2018

Polymer-Free BioFreedom Stent as Safe as Orsiro, but Not as Effective

News Conference News TCT 2018

CORRECTION: Polymer-Free BioFreedom Stent Faces Off Against Orsiro

Michael O'Riordan

September 22, 2018

News Conference News TCT 2018

EXCEL Deep Dive: Repeat Revascularization, Medical Therapy, and Anemia All Impact Patient Prognosis

Michael O'Riordan

September 21, 2018

News Daily News

Long-term Off-Pump CABG Results Deflate in Large, Real-world Study

L.A. McKeown

September 20, 2018

News Conference News ESC 2018

Myocardial Injury or MI? New Universal Definition Aims for Clarity

Todd Neale

September 05, 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2018

Caitlin E. Cox

September 04, 2018

News Conference News ESC 2018

SCOT-HEART: A Win for CT Angiography in Chest Pain Workup Prompts Cacophony of Reactions

Shelley Wood

August 31, 2018

News Conference News ESC 2018

New ESC/EACTS Revascularization Guidelines Make Room for Radial First, STICH, and DES for All

Michael O'Riordan

August 29, 2018

News Conference News ESC 2018

Omega-3 Fatty Acids Fail to Reduce CVD Events in Diabetic Patients: ASCEND

Michael O'Riordan

August 26, 2018

News Daily News

Coronary Microvascular Dysfunction May Be a Marker of CV Risk in Obese Patients

L.A. McKeown

August 09, 2018

News Conference News SCCT 2018

Marijuana May Muddle a Chest Pain Diagnosis, CTA Study Hints

Yael L. Maxwell

July 18, 2018

News Daily News

Rivaroxaban Offers Net Reduction in Fatal or Irreversible Events in ACS: ATLAS ACS-2 TIMI-51

Michael O'Riordan

July 06, 2018

News Daily News

SGLT2 Inhibitors Work in Type 2 Diabetes Across Levels of CV Risk, Renal Function

Todd Neale

July 02, 2018

News Features

The M Word: Is Routine Transfemoral PCI Defensible in 2018?

Todd Neale

June 08, 2018

Advertisement

TCTMD’s Top 10 Most Popular Stories for November 2018

Female Cardiologists and Interventionalists Rare, Isolated in Australia and New Zealand

ODYSSEY Outcomes Published as New Cholesterol Guidelines Loom

SORT-OUT IX: Statistical Mix-up Turns Trial’s Primary Endpoint Around

AHA 2018: New Cholesterol Guidelines, Fish Oil, Diabetes Meds, and Inflammation Blow Into the Windy City

The Price of Knowledge: Industry-Sponsored Studies in the Era of Evidence-Based Medicine

Twitter, Bias, and Trial Tweaks: ISCHEMIA Invites Debate on Study Designs and Endpoint Combos

CORRECTION: Polymer-Free BioFreedom Stent Faces Off Against Orsiro

EXCEL Deep Dive: Repeat Revascularization, Medical Therapy, and Anemia All Impact Patient Prognosis

Long-term Off-Pump CABG Results Deflate in Large, Real-world Study

Myocardial Injury or MI? New Universal Definition Aims for Clarity

TCTMD’s Top 10 Most Popular Stories for August 2018

SCOT-HEART: A Win for CT Angiography in Chest Pain Workup Prompts Cacophony of Reactions

New ESC/EACTS Revascularization Guidelines Make Room for Radial First, STICH, and DES for All

Omega-3 Fatty Acids Fail to Reduce CVD Events in Diabetic Patients: ASCEND

Coronary Microvascular Dysfunction May Be a Marker of CV Risk in Obese Patients

Marijuana May Muddle a Chest Pain Diagnosis, CTA Study Hints

Rivaroxaban Offers Net Reduction in Fatal or Irreversible Events in ACS: ATLAS ACS-2 TIMI-51

SGLT2 Inhibitors Work in Type 2 Diabetes Across Levels of CV Risk, Renal Function

The M Word: Is Routine Transfemoral PCI Defensible in 2018?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content